Trade Mark Journal No.2026/023 5 June 2026
UK00004382932 5 May 2026 (5,42,44)
ANIMINIBODY
International priority date claimed: 16 December 2025
(United States of America)
(99/549,988)
- Class 5
- Veterinary pharmaceutical preparations for the treatment of chronic diseases being viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune related diseases; Therapeutic pharmaceutical for the treatment of chronic diseases being viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune related diseases; Antibodies for veterinary purposes.
- Class 42
- Biotechnology research; Research and development in the field of biotechnology; Pharmaceutical research and development; Research and development in the field of veterinary medicine; Research and development in the field of biopharmaceuticals.
- Class 44
- Providing veterinary information; Providing health information in the field of chronic diseases; Providing health information; Providing animal health information via a website; Providing information in the field of veterinary medicine.
Animerra, Inc.
Representative: D Young & Co LLP